HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc
Previous close
$4.90
Day range
$4.92 - $5.21
Year range
$2.94 - $6.95
Market cap
291.74M USD
Avg Volume
156.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 9.25M | 223.77% |
Operating expense | 6.80M | 6.99% |
Net income | -21.66M | -11.08% |
Net profit margin | -234.28 | 65.69% |
Earnings per share | -0.37 | -21.80% |
EBITDA | -18.79M | 19.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 158.89M | -34.81% |
Total assets | 198.10M | -30.24% |
Total liabilities | 306.60M | -6.95% |
Total equity | -108.50M | — |
Shares outstanding | 58.70M | — |
Price to book | -2.55 | — |
Return on assets | -24.31% | — |
Return on capital | 72.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -21.66M | -11.08% |
Cash from operations | -22.27M | 9.17% |
Cash from investing | 13.23M | -40.64% |
Cash from financing | 581.00K | 14,425.00% |
Net change in cash | -8.46M | -280.31% |
Free cash flow | -29.22M | -566.14% |
About
Founded
2015
Website
Employees
106
